Metoprolol Succinate
Product Images NDC 68071-2331

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68071-2331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2331 1)

Pdp (68071 2331 1)
Label for Metoprolol Succinate 50mg extended-release tablets by NuCare Pharmaceuticals, Inc. The label shows a quantity of 100 tablets and includes manufacturer details listing Novast Laboratories Ltd. in China. It contains multiple barcodes and batch information fields, with storage instructions to keep at controlled temperature 59-86°F and a warning to keep out of reach of children.*
FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagram showing the molecular arrangement of the active ingredient in Metoprolol Succinate by NuCare Pharmaceuticals, Inc. The structure details functional groups and molecular connections relevant to the compound.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for various patient subgroups. It compares Metoprolol Succinate Extended-Release Tablets versus placebo across three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include regional location, NYHA class, ejection fraction, ischemic etiology, sex, race, previous myocardial infarction, diabetes status, hypertension status, and heart rate. The x-axis scales from 0.0 to 2.0, indicating favorability towards Metoprolol Succinate or placebo for each outcome.*
FDA Label Image

Image-03 (Image 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.